Results 121 to 130 of about 1,155 (183)

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]

ESMO Open
Yap TA, Choudhury AD, Hamilton E, Rosen LS, Stratton KL, Gordon MS, Schaer D, Liu L, Zhang L, Mittapalli RK, Zhong W, Soman N, Tolcher AW.   +12 more
europepmc   +1 more source

Riesgos geológicos : terremotos

, 2008
Alonso Chaves, Francisco Manuel, García Navarro, Encarnación, Mantero Romero, Elena María   +2 more
openaire   +1 more source

The role of anhedonia symptoms in symptomatology of posttraumatic stress disorder and related functional impairments among traumatized Chinese adults. [PDF]

Eur J Psychotraumatol
Wan J, Fang R, Liu P, Bi Y, Luo S, Cao C, Wang L.   +6 more
europepmc   +1 more source

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception. [PDF]

Cancer Discov
Winslow MM, Ahmed MA, Berg CD, Black JRM, Downward J, Govindan R, Herbst RS, Heymach JV, Jaffee EM, Kraut N, Merad M, Meyerson M, Pandya T, Politi K, Rao AV, Rudin CM, Soria JC, Tang YJ, Wong KK, Yap TA, Swanton C, AACR Lung Cancer Task Force.   +21 more
europepmc   +1 more source

¿Otro terremoto?

, 2009
openaire   +1 more source

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. [PDF]

Clin Cancer Res
Siu LL, Yap TA, Genta S, Pennock G, Hicking C, Vagge DS, Mukker JK, Locatelli G, Tolcher AW.   +8 more
europepmc   +1 more source

Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations. [PDF]

ESMO Open
Methodology for the Development of Innovative Cancer Therapies Taskforce. Electronic address: lseymour@ctg.queensu.ca.
europepmc   +1 more source

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. [PDF]

Oncologist
Torrado C, Andersen CR, Kang L, Brink AL, Adesoye T, Le H, Patterson CJ, Poullard A, Osburn JA, Tan HN, Gouda MA, Charles S, Urschel GE, Tang TY, Hong DS, Champiat S, Naing A, Tsimberidou AM, Dumbrava EE, Piha-Paul SA, Rodon J, Yap TA, Pohlmann PR, Meric-Bernstam F, Fu S.   +24 more
europepmc   +1 more source

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. [PDF]

Cancer Res Commun
Braganca Xavier C, Andersen CR, Lim J, Slade JH, Bean SA, Kang L, Le H, Tsimberidou AM, Naing A, Hong DS, Dumbrava EE, Rodon Ahnert J, Pohlmann PR, Piha-Paul SA, Champiat S, Yap TA, Tang TY, Meric-Bernstam F, Fu S.   +18 more
europepmc   +1 more source